Want to join the conversation?
$ES 2Q15 Call: Excluding merger related costs, we earned $209.6MM or $0.66 per share in 2Q15 vs. $131.9MM or $0.42 in 2Q14. In 1H15, we earned $466.9MM or $1.47 per share vs. $373.7MM or $1.18 in 1H14. These results strongly support our FY15 earnings projection of $2.75-2.90 per share and targeted long-term annual earnings growth rate of 6-8%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?